Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles
 

Open Access

Review Article

J App Pharm Sci. 2021; 11(10): 134-139


Vanishing bile duct syndrome in pediatric population: An updated case-based review

H. C. Gopika Nair, Shilpa Rachel Thomas, S. I. Prithika, P. Ajay Samraj, K. Sumathi, Keerthana Chandrasekar.

Abstract
Vanishing bile duct syndrome (VBDS) is a rare and rapidly progressing condition where there is massive destruction or loss of the bile duct. The etiology of VBDS includes developmental abnormalities, immune-mediated, infectious disorders, drug-induced, neoplastic, and ischemic disorders. Certain drugs that are responsible for the development of this disease are non-steroidal anti-inflammatory drugs, sex steroids, antidepressants, immunomodulators, and antibiotics. The exact mechanism behind the progression of this condition is not established. The clinical presentation ranges from the presence of dark urine, discolored stools, pruritus, maculopapular rashes, jaundice, and liver failure in extreme cases. A confirmatory test for the diagnosis of VBDS is the presence of ductopenia, which is a 50% reduction of the interlobular bile duct in liver biopsy. Currently, treatment is to remove the offending agent and provide supportive care with drugs like Ursodeoxycholic acid, corticosteroids, and immunosuppressants. Prognosis varies from hepatic failure to liver transplantation and it may also result in death. This case-based review briefs the seven documented pediatric cases of acute drug-related VBDS. Based on these articles, different treatment options were analyzed to provide a better prognosis for patients who are suffering from VBDS.

Key words: Vanishing bile duct syndrome, Etiology, Pharmacological Treatment, Quality of life



Similar Articles

Photoacoustic image-guided corpus cavernosum intratunical injection of adipose stem cell-derived exosomes loaded polydopamine thermosensitive hydrogel for erectile dysfunction treatment.
Liang L, Shen Y, Dong Z, Gu X
Bioactive materials. 2022; 9(): 147-156

Event-Driven Acquisition and Machine-Learning-Based Efficient Prediction of the Li-Ion Battery Capacity.
Mian Qaisar S, AbdelGawad AEE, Srinivasan K
SN computer science. 2022; 3(1): 15

Boosting proteolytic pathways as a treatment against glycation-derived damage in the brain?
Taylor A, Bejarano E
Neural regeneration research. 2022; 17(2): 320-322

Safe Zones for Percutaneous Carpal Tunnel Release.
Wu PT, Chern TC, Wu TT, Shao CJ, Wu KC, Kuo LC, Jou IM
Hand clinics. 2022; 38(1): 83-90

Exosome treatment for stroke with diabetic comorbidity.
Venkat P, Chopp M
Neural regeneration research. 2022; 17(2): 315-317


Full-text options


Latest Statistics about COVID-19
• pubstat.org


Add your Article(s) to Indexes
• citeindex.org






Covid-19 Trends and Statistics
ScopeMed.com
CiteIndex.org
CancerLine
FoodsLine
PhytoMedline
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.



ScopeMed Web Sites